Evaluation of Prognostic Factors in Patients with Relapse and Unresectable Biliary Tract Cancer, Treated with S-1 after Failure of Gemcitabine

Prognostic factors for patients with relapse and unresectable biliary tract cancer, treated with Tegafur Gimeracil Oteracil Potassium (S-1) after failure of gemcitabine (GEM), are unclear. We searched for prognostic factors in patients with relapse and unresectable biliary tract cancer treated with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	YAKUGAKU ZASSHI 2022/09/01, Vol.142(9), pp.1021-1029
Hauptverfasser:	Nakai, Masato, Kikkawa, Akiyoshi, Funahara, Hiroko, Matsumoto, Shunji, Hiraki, Koichi
Format:	Artikel
Sprache:	jpn
Schlagworte:	biliary tract cancer prognostic factor Tegafur Gimeracil Oteracil Potassium
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!